Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

NCT02400359 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Weight Loss

Interventions

DRUG: Lorcaserin HCl
DRUG: Placebo

Sponsor

Beth Israel Deaconess Medical Center